Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email [email protected] in the first instance.

 Information  X 
Enter a valid email address

Virotec Intl Ld (VTI)

  Print      Mail a friend

Monday 07 August, 2006

Virotec Intl Ld

Contract for radium removal

Virotec International Ld
07 August 2006

                            VIROTEC INTERNATIONAL LTD

7 August 2006

 Ten-Year US$619,000 Contract Signed for Removal of Radium from Drinking Water

The Directors of Virotec International Ltd ('Virotec') (AIM: VTI) are pleased to
announce that Virotec AquaSolve LLC ('AquaSolve') has entered into its first
contract to licence ViroFlowTM Technology, which uses the ViroFilterTM System to
treat drinking water. This system will be installed in South Carolina, USA and
is a specifically designed filter system using Virotec's Radium ProActivTM
reagent to remove Radium contamination in drinking water.

The consideration of US$619,000 will be paid over the ten-year life of the
contract, and is calculated based on the volume of well water pumped through the
ViroFilterTM System (the 'System').

The contract has been won by the recently formed joint venture company,
AquaSolve which is 66.7% owned by Virotec (see below for more information on

ViroFilterTM Systems are installed at the well head and provide to water
companies the ability to reduce the level of naturally occurring Radium,
allowing them to deliver safe water to their customers and facilitating
compliance with their relevant regulatory guidelines.

The Executive Chairman, Brian Sheeran stated 'Whilst this contract is for a
small volume well, we believe it is a clear demonstration of the commercial
acceptance of our System in this region. This is a widespread problem, with up
to 1,000 water wells in the southern states of the USA currently affected by
naturally occurring Radium contamination. Virotec now has the capacity to
support and service a large portion of the target market due to the construction
of its new production facility at Walterboro, South Carolina.'

Mr Sheeran added 'As advised to the market on 30 June 2006, at a public meeting
held in South Carolina sponsored by the Department of Heath and Environmental
Control ('DHEC'), our Technology was introduced to customers of the
Gilbert-Summit Rural Water District as the solution to their problem of
naturally occurring Radium found in their ground water.  Since this meeting,
interest in our solution has been significant and we anticipate this interest
will lead to further contracts in the short term'.

For further information please contact Angus Craig, Company Secretary on +617
5530 8014 or by email to [email protected]

Additional Information on Virotec AquaSolve LLC ('AquaSolve')

AquaSolve is a specialty water treatment company based in South Carolina, and is
66.7% owned by Virotec and 33.3% owned by CW Partners, part of the Wade Craven

AquaSolve has been licenced by Virotec to market ViroFlowTM Technology and
systems using Radium ProActivTM, Arsenic ProActivTM and ViroPhosTM reagents for
removal of Radium, Arsenic, and Phosphate, respectively, in South Carolina,
North Carolina, Virginia, and Georgia. In addition to the above, the AquaSolve
team is assisting with the development of new systems to address other
environmental problems in the region.

AquaSolve has also assisted in the Radium ProActivTM reagent being certified by
the National Sanitation Foundation ('NSF') in the USA for use in the treatment
of drinking water.

                           VIROTEC INTERNATIONAL LTD
                               ABN 81 004 801 398
                                   PO Box 188
                            Sanctuary Cove QLD 4212

                      This information is provided by RNS
            The company news service from the London Stock Exchange

a d v e r t i s e m e n t